• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Stealthy MetaModix looks for new approach to diabetes, bariatric surgery

Stealthy MetaModix looks for new approach to diabetes, bariatric surgery

February 18, 2011 By MedCity News

A stealthy Minnesota medical device company is moving ahead with plans to develop a minimally invasive approach to bariatric surgery and better solve the problem of Type II diabetes.

MetaModix is one-third of the way through a $1.9 million angel round, according to a federal regulatory filing and company executives. It is using the money to develop its product and perform some preclinical testing. MetaModix hopes to be in European clinical trials by early next year, said Kedar Belhe, the company’s chief executive officer.

Belhe said the company is “developing a cost-effective minimally invasive therapy for Type II diabetes” that mimics “certain elements of bariatric surgery through an endoscopic procedure.” The process would be an out-patient procedure that would last about 30 minutes, said Belhe, who worked in both the atrial-fibrillation and cardiovascular divisions at St. Jude Medical (NYSE:STJ).

MedCity News logo

Belhe declined to say more citing the competitive nature of the space. There are scores of startups offering different approaches to obesity and diabetes eager to address the $174 billion in costs related to diabetes each year. The Food & Drug Administration just broadened the use of Allergan’s Lap-Band device to include more patients, for example, and other approaches range from stomach stapling, embedding sensors or inserting sleeves in the body.

Bariatric surgery often eliminates a patient’s Type II diabetes. However, there are concerns over the procedure itself, ranging from post-operative side effects to its long-term impact.

MetaModix has been developing its new approach since the company started in May 2009. The company previously worked with university engineering students in Minnesota developing an intestinal liner to address diabetes. But the company is no longer working on that project, Belhe said.

GI Dynamics, based in Lexington, Mass., is developing a gut liner along similar lines that has shown promise in relieving the symptoms of diabetes.

Filed Under: News Well Tagged With: Angel Investment, Bariatrics, MetaModix

More recent news

  • Medtronic partners with IRCAD on Hugo, Affera surgical training
  • 23andMe co-founder wins bid to take back control of company
  • Neurent Medical opens new manufacturing facility in Ireland
  • Brain Navi wins FDA nod for neurosurgical robot
  • Adona Medical completes enrollment in first-in-human interatrial shunt trial

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy